| abstract |
The invention relates to novel N-phenylacetyl and related acyl derivatives (4-amino-2,6-dimethylphenylsulfonyl) nitromethane and to their pharmaceutically acceptable salt-inhibiting salts reductase and are useful e.g. in the treatment of certain peripheral effects of diabetes and galactosemia. Pharmaceutical preparations containing one of the derivatives and methods for the preparation of derivatives and the use of derivatives are also described. |